Synthesis of enantiomerically pure (2R,5S)- and (2R,5R)-5-hydroxypipecolic acid from glycinate Schiff bases

Tetrahedron Asymmetry

Volumn 7, Issue 9, 1996, Pages 2585-2593

  Hoarau, Sylvie ^a   Fauchère, Jean Luc ^b   Pappalardo, Louis ^a   Roumestant, Marie Louise ^a   Viallefont, Philippe ^a  

^a UNIV MONTPELLIER   (France)

^b INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PIPECOLIC ACID DERIVATIVE;

ALKYLATION; ARTICLE; DRUG SYNTHESIS; ENANTIOMER; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; REACTION ANALYSIS; STEREOCHEMISTRY;

EID: 0030250010     PISSN: 09574166     EISSN: None     Source Type: Journal    
DOI: 10.1016/0957-4166(96)00332-1     Document Type: Article

References (27)

1. 1. The configuration of the 5-hydroxypipecolic acid derivatives is indicated in one of the following ways: position 5: cis-and irons-hydroxy or 5R and 5S, respectively; position 2 : D and L-aminoacid or 2R and 2S, respectively.
2. 2. (a) Witkop B., Foltz C. M., J. Am. Chem. Soc. 1957, 79, 192.
3. (b) Kondo Y., J. Sericult. Sci. Japan 1957, 26, 345. S.
4. (c) Goas G., Larher F., Goas M., C. R. Acad. Sc. Paris 1970, 271, 1368.
5. (d) Fowden L., Progress in Phytochemistry, Eds. L. Reinhold and Y. Liwischitz, Wiley London, 1970, 2, 203.
6. (e) Hatanaka I., Sci. Pap. Coll. Gen. Educ. Univ. Tokyo 1972, 22, 117.
7. (f) Despontin J., Marlier M., and Dardenne G., Phytochemistry 1977, 16, 387.
8. 3. Mester L., Szabados L., Mester M., Yadav N., Planta Medica 1979, 35, 339.
9. 4. (a) Fujii T., Murai M., Morimoto H., Maeda Y., Yamaoka M., Hagiwara D., Miyake H., Ikari N., Matsuo M., Br. J. Pharmacol. 1992, 107, 785.
10. (b) Koehn F. E., McConnell O. J., Longley R. E., Sennett S. H., and Reed J. K., J. Med. Chem. 1994, 37, 3181.
11. 5. (a) Copeland T. D., Wondrak E. M., Tozser J., Roberts M. M., Oroszlan S., Biochem. Biophys. Res. Commun. 1990, 169, 310.
12. (b) Itazaki H., Nagashima K., Sugita K., Yoshida H., Kawamura Y., Yasuda Y., Matsumoto K., Ishii K., Uotani N., Nakai H., Terui A., Yoshimatsu S., Ikenishi Y., Nakagawa Y., J. Antibiotics 1990, 1524.
13. 6. (a) Beyerman H. C., Boekee P., Rec. Trav. Chim. Pays Bas 1959, 78, 648.
14. (b) Fujita Y., Irreverre F., Witkop B., J. Am. Chem. Soc. 1964, 86, 1844.
15. (c) Callens R. E. A., Anteunis M. J. O., Reyniers F., Bull. Soc. Chim. Belg. 1982, 91, 713.
16. (d) Bailey P. D., Bryans J. S., Tetrahedron Lett. 1988, 29, 2231.
17. (e) Herdeis C., Engel W., Tetrahedron Asymmetry 1991, 2, 945.
18. (f) Herdeis C., Heller H., Tetrahedron Asymmetry 1993, 4, 2085.
19. (g) Herdeis C., Held W. A., and Kirfel A., Liebigs Ann. Chem. 1994, 1117
20. 7. Tabcheh M., El. Achqar A., Pappalardo L., Roumestant M. L., and Viallefont Ph., Tetrahedron 1991, 47, 4611.
21. 3OH, which was possible only with pyrrolidine structure); 190; 170; 146.
22. 9. Bajwa J. S., Anderson R. C., Tetrahedron Lett. 1991, 32, 3021.
23. 2Ph), 7.26 (5H, s, Ph).
24. 11. Cavelier F., Rolland M., Verducci J., Org. prep. proc. int. Briefs 1994, 26, 608.
25. 12. 2-hydroxypinan-3-one was prepared by the method of H. Schmidt, Chem. Ber. 1960, 93, 2485.
26. 13. Lange G. L., Gottardo C., Synthetic commun.1990, 20, 1473.
27. 14. Preparation of nBuLi / ether: P. Roussel, J. Metzger, Bull. Soc. Chim. France 1962, 2075.